No Data
Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts
Pacific Biosciences (NASDAQ:PACB) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below summarizes their recent ratings, sho
Stocks With More Than 10% Short Interest - Finviz Screener
Scotiabank Sticks to Its Buy Rating for Pacific Biosciences (PACB)
Pacific Biosciences Is Maintained at Neutral by Piper Sandler
Pacific Biosciences Is Maintained at Neutral by Piper Sandler
Express News | Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $2
The Pacific Biosciences of California, Inc. (NASDAQ:PACB) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Pacific Biosciences of California, Inc. (NASDAQ:PACB) just released its latest first-quarter report and things are not looking great. The numbers were fairly weak, with revenue of US$39m missing
ed_tcs : careful with this share... i lost alot